• レポートコード:MRC2-11QY13651 • 出版社/出版日:QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、95ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:医療、製薬 |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はアレルギー性接触皮膚炎(ACDS)のグローバル市場について調査・分析したレポートです。種類別(糖質コルチコイド、外用ステロイド、その他外用剤、コルチコステロイド、抗コリン作用性制吐剤、その他抗不安薬、鎮静剤・催眠剤)市場規模、用途別(局所投与、経口投与)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別アレルギー性接触皮膚炎(ACDS)の競争状況、市場シェア ・世界のアレルギー性接触皮膚炎(ACDS)市場:種類別市場規模 2015年-2020年(糖質コルチコイド、外用ステロイド、その他外用剤、コルチコステロイド、抗コリン作用性制吐剤、その他抗不安薬、鎮静剤・催眠剤) ・世界のアレルギー性接触皮膚炎(ACDS)市場:種類別市場規模予測 2021年-2026年(糖質コルチコイド、外用ステロイド、その他外用剤、コルチコステロイド、抗コリン作用性制吐剤、その他抗不安薬、鎮静剤・催眠剤) ・世界のアレルギー性接触皮膚炎(ACDS)市場:用途別市場規模 2015年-2020年(局所投与、経口投与) ・世界のアレルギー性接触皮膚炎(ACDS)市場:用途別市場規模予測 2021年-2026年(局所投与、経口投与) ・北米のアレルギー性接触皮膚炎(ACDS)市場分析:米国、カナダ ・ヨーロッパのアレルギー性接触皮膚炎(ACDS)市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのアレルギー性接触皮膚炎(ACDS)市場分析:日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のアレルギー性接触皮膚炎(ACDS)市場分析:メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのアレルギー性接触皮膚炎(ACDS)市場分析:トルコ、サウジアラビア、UAE等 ・企業情報(企業概要、製品概要、販売量、企業動向) - 掲載企業(変更可能性あり):Sandoz、Akorn、Perrigo Company、Taro Pharmaceuticals、Teva Pharmaceuticals、Glenmark Pharmaceuticals ・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Allergic contact dermatitis (ACD) is a common inflammatory skin disorder and an alternative form of contact dermatitis. It is manifestation of allergic responses caused by the contact of an allergic substance such as, nickel, gold, chromium, mercaptobenzothiazole, formaldehyde and many more. The other form of contact dermatitis is irritant contact dermatitis (ICD). Symptoms of allergic contact dermatitis (ACDs) are similar to that of irritant contact dermatitis, which makes the diagnosis harder. The symptoms of allergic contact dermatitis include presence of the skin lesion or rashes at the exposure site. Depending on the allergen type, it may form blisters, papules, simple red spots, vesicles and rashes. The rash can drain, ooze or crust and also becomes raw, thickened or scaled. Allergic contact dermatitis (ACD) is caused as a result of two stages, first stage sensitize and primes the immune system for allergic responses and the second stage, triggers it. The diagnosis of allergic contact dermatitis includes physical examination and medical therapy. The precise diagnosis based on the symptoms and by rash appearance is very rare. The intermittent or chronic rashes that are not clarified by historical data and physical examination often requires further testing. A patch test (contact delayed hypersensitivity allergy test) is a normally used to detect the actual cause of allergic contact dermatitis.
The global allergic contact dermatitis (ACDS) market is projected to experience rapid growth with increasing prevalence of the diseases and frequently changing lifestyle. The increased focus for the medical treatment of allergic contact dermatitis with perception of providing a comfortable and healthy life, the global allergic contact dermatitis (ACDS) market is anticipated to increase during the forecast period. The key driver of the global allergic contact dermatitis (ACDS) market is the effectiveness of the treatment by reducing the effect of the symptoms. The Increased government concern and improvement in healthcare sectors are some factors facilitating the growth of allergic contact dermatitis (ACDS) market globally. The scarcity of the qualified specialists, equipped amenities, and other skilled professionals for the treatment of allergic contact dermatitis are few factors responsible for restraining the overall growth of the allergic contact dermatitis (ACDS) market.
Market Analysis and Insights: Global Allergic Contact Dermatitis (ACDS) Market
The global Allergic Contact Dermatitis (ACDS) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Allergic Contact Dermatitis (ACDS) Scope and Market Size
Allergic Contact Dermatitis (ACDS) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Allergic Contact Dermatitis (ACDS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sandoz
Akorn
Perrigo Company
Taro Pharmaceuticals
Teva Pharmaceuticals
Glenmark Pharmaceuticals
…
Market segment by Type, the product can be split into
Glucocorticoids
Topical Steroids
Miscellaneous Topical Agents
Corticosteroid
Anticholinergic Antiemetic
Miscellaneous Anxiolytics, Sedatives and Hypnotics
Market segment by Application, split into
Topical Administration
Oral Administration
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Allergic Contact Dermatitis (ACDS) Revenue
1.4 Market by Type
1.4.1 Global Allergic Contact Dermatitis (ACDS) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Glucocorticoids
1.4.3 Topical Steroids
1.4.4 Miscellaneous Topical Agents
1.4.5 Corticosteroid
1.4.6 Anticholinergic Antiemetic
1.4.7 Miscellaneous Anxiolytics, Sedatives and Hypnotics
1.5 Market by Application
1.5.1 Global Allergic Contact Dermatitis (ACDS) Market Share by Application: 2020 VS 2026
1.5.2 Topical Administration
1.5.3 Oral Administration
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Allergic Contact Dermatitis (ACDS) Market Perspective (2015-2026)
2.2 Global Allergic Contact Dermatitis (ACDS) Growth Trends by Regions
2.2.1 Allergic Contact Dermatitis (ACDS) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Allergic Contact Dermatitis (ACDS) Historic Market Share by Regions (2015-2020)
2.2.3 Allergic Contact Dermatitis (ACDS) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Allergic Contact Dermatitis (ACDS) Market Growth Strategy
2.3.6 Primary Interviews with Key Allergic Contact Dermatitis (ACDS) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Allergic Contact Dermatitis (ACDS) Players by Market Size
3.1.1 Global Top Allergic Contact Dermatitis (ACDS) Players by Revenue (2015-2020)
3.1.2 Global Allergic Contact Dermatitis (ACDS) Revenue Market Share by Players (2015-2020)
3.1.3 Global Allergic Contact Dermatitis (ACDS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Allergic Contact Dermatitis (ACDS) Market Concentration Ratio
3.2.1 Global Allergic Contact Dermatitis (ACDS) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Allergic Contact Dermatitis (ACDS) Revenue in 2019
3.3 Allergic Contact Dermatitis (ACDS) Key Players Head office and Area Served
3.4 Key Players Allergic Contact Dermatitis (ACDS) Product Solution and Service
3.5 Date of Enter into Allergic Contact Dermatitis (ACDS) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Allergic Contact Dermatitis (ACDS) Historic Market Size by Type (2015-2020)
4.2 Global Allergic Contact Dermatitis (ACDS) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020)
5.2 Global Allergic Contact Dermatitis (ACDS) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Allergic Contact Dermatitis (ACDS) Market Size (2015-2020)
6.2 Allergic Contact Dermatitis (ACDS) Key Players in North America (2019-2020)
6.3 North America Allergic Contact Dermatitis (ACDS) Market Size by Type (2015-2020)
6.4 North America Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Allergic Contact Dermatitis (ACDS) Market Size (2015-2020)
7.2 Allergic Contact Dermatitis (ACDS) Key Players in Europe (2019-2020)
7.3 Europe Allergic Contact Dermatitis (ACDS) Market Size by Type (2015-2020)
7.4 Europe Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020)
8 China
8.1 China Allergic Contact Dermatitis (ACDS) Market Size (2015-2020)
8.2 Allergic Contact Dermatitis (ACDS) Key Players in China (2019-2020)
8.3 China Allergic Contact Dermatitis (ACDS) Market Size by Type (2015-2020)
8.4 China Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Allergic Contact Dermatitis (ACDS) Market Size (2015-2020)
9.2 Allergic Contact Dermatitis (ACDS) Key Players in Japan (2019-2020)
9.3 Japan Allergic Contact Dermatitis (ACDS) Market Size by Type (2015-2020)
9.4 Japan Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Allergic Contact Dermatitis (ACDS) Market Size (2015-2020)
10.2 Allergic Contact Dermatitis (ACDS) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Allergic Contact Dermatitis (ACDS) Market Size by Type (2015-2020)
10.4 Southeast Asia Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020)
11 India
11.1 India Allergic Contact Dermatitis (ACDS) Market Size (2015-2020)
11.2 Allergic Contact Dermatitis (ACDS) Key Players in India (2019-2020)
11.3 India Allergic Contact Dermatitis (ACDS) Market Size by Type (2015-2020)
11.4 India Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Allergic Contact Dermatitis (ACDS) Market Size (2015-2020)
12.2 Allergic Contact Dermatitis (ACDS) Key Players in Central & South America (2019-2020)
12.3 Central & South America Allergic Contact Dermatitis (ACDS) Market Size by Type (2015-2020)
12.4 Central & South America Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sandoz
13.1.1 Sandoz Company Details
13.1.2 Sandoz Business Overview
13.1.3 Sandoz Allergic Contact Dermatitis (ACDS) Introduction
13.1.4 Sandoz Revenue in Allergic Contact Dermatitis (ACDS) Business (2015-2020))
13.1.5 Sandoz Recent Development
13.2 Akorn
13.2.1 Akorn Company Details
13.2.2 Akorn Business Overview
13.2.3 Akorn Allergic Contact Dermatitis (ACDS) Introduction
13.2.4 Akorn Revenue in Allergic Contact Dermatitis (ACDS) Business (2015-2020)
13.2.5 Akorn Recent Development
13.3 Perrigo Company
13.3.1 Perrigo Company Company Details
13.3.2 Perrigo Company Business Overview
13.3.3 Perrigo Company Allergic Contact Dermatitis (ACDS) Introduction
13.3.4 Perrigo Company Revenue in Allergic Contact Dermatitis (ACDS) Business (2015-2020)
13.3.5 Perrigo Company Recent Development
13.4 Taro Pharmaceuticals
13.4.1 Taro Pharmaceuticals Company Details
13.4.2 Taro Pharmaceuticals Business Overview
13.4.3 Taro Pharmaceuticals Allergic Contact Dermatitis (ACDS) Introduction
13.4.4 Taro Pharmaceuticals Revenue in Allergic Contact Dermatitis (ACDS) Business (2015-2020)
13.4.5 Taro Pharmaceuticals Recent Development
13.5 Teva Pharmaceuticals
13.5.1 Teva Pharmaceuticals Company Details
13.5.2 Teva Pharmaceuticals Business Overview
13.5.3 Teva Pharmaceuticals Allergic Contact Dermatitis (ACDS) Introduction
13.5.4 Teva Pharmaceuticals Revenue in Allergic Contact Dermatitis (ACDS) Business (2015-2020)
13.5.5 Teva Pharmaceuticals Recent Development
13.6 Glenmark Pharmaceuticals
13.6.1 Glenmark Pharmaceuticals Company Details
13.6.2 Glenmark Pharmaceuticals Business Overview
13.6.3 Glenmark Pharmaceuticals Allergic Contact Dermatitis (ACDS) Introduction
13.6.4 Glenmark Pharmaceuticals Revenue in Allergic Contact Dermatitis (ACDS) Business (2015-2020)
13.6.5 Glenmark Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Allergic Contact Dermatitis (ACDS) Key Market Segments
Table 2. Key Players Covered: Ranking by Allergic Contact Dermatitis (ACDS) Revenue
Table 3. Ranking of Global Top Allergic Contact Dermatitis (ACDS) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Allergic Contact Dermatitis (ACDS) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Glucocorticoids
Table 6. Key Players of Topical Steroids
Table 7. Key Players of Miscellaneous Topical Agents
Table 8. Key Players of Corticosteroid
Table 9. Key Players of Anticholinergic Antiemetic
Table 10. Key Players of Miscellaneous Anxiolytics, Sedatives and Hypnotics
Table 11. Global Allergic Contact Dermatitis (ACDS) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Allergic Contact Dermatitis (ACDS) Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Allergic Contact Dermatitis (ACDS) Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Allergic Contact Dermatitis (ACDS) Market Share by Regions (2015-2020)
Table 15. Global Allergic Contact Dermatitis (ACDS) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Allergic Contact Dermatitis (ACDS) Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Allergic Contact Dermatitis (ACDS) Market Growth Strategy
Table 21. Main Points Interviewed from Key Allergic Contact Dermatitis (ACDS) Players
Table 22. Global Allergic Contact Dermatitis (ACDS) Revenue by Players (2015-2020) (Million US$)
Table 23. Global Allergic Contact Dermatitis (ACDS) Market Share by Players (2015-2020)
Table 24. Global Top Allergic Contact Dermatitis (ACDS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allergic Contact Dermatitis (ACDS) as of 2019)
Table 25. Global Allergic Contact Dermatitis (ACDS) by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Allergic Contact Dermatitis (ACDS) Product Solution and Service
Table 28. Date of Enter into Allergic Contact Dermatitis (ACDS) Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Allergic Contact Dermatitis (ACDS) Market Size by Type (2015-2020) (Million US$)
Table 31. Global Allergic Contact Dermatitis (ACDS) Market Size Share by Type (2015-2020)
Table 32. Global Allergic Contact Dermatitis (ACDS) Revenue Market Share by Type (2021-2026)
Table 33. Global Allergic Contact Dermatitis (ACDS) Market Size Share by Application (2015-2020)
Table 34. Global Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020) (Million US$)
Table 35. Global Allergic Contact Dermatitis (ACDS) Market Size Share by Application (2021-2026)
Table 36. North America Key Players Allergic Contact Dermatitis (ACDS) Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Allergic Contact Dermatitis (ACDS) Market Share (2019-2020)
Table 38. North America Allergic Contact Dermatitis (ACDS) Market Size by Type (2015-2020) (Million US$)
Table 39. North America Allergic Contact Dermatitis (ACDS) Market Share by Type (2015-2020)
Table 40. North America Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020) (Million US$)
Table 41. North America Allergic Contact Dermatitis (ACDS) Market Share by Application (2015-2020)
Table 42. Europe Key Players Allergic Contact Dermatitis (ACDS) Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Allergic Contact Dermatitis (ACDS) Market Share (2019-2020)
Table 44. Europe Allergic Contact Dermatitis (ACDS) Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Allergic Contact Dermatitis (ACDS) Market Share by Type (2015-2020)
Table 46. Europe Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Allergic Contact Dermatitis (ACDS) Market Share by Application (2015-2020)
Table 48. China Key Players Allergic Contact Dermatitis (ACDS) Revenue (2019-2020) (Million US$)
Table 49. China Key Players Allergic Contact Dermatitis (ACDS) Market Share (2019-2020)
Table 50. China Allergic Contact Dermatitis (ACDS) Market Size by Type (2015-2020) (Million US$)
Table 51. China Allergic Contact Dermatitis (ACDS) Market Share by Type (2015-2020)
Table 52. China Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020) (Million US$)
Table 53. China Allergic Contact Dermatitis (ACDS) Market Share by Application (2015-2020)
Table 54. Japan Key Players Allergic Contact Dermatitis (ACDS) Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Allergic Contact Dermatitis (ACDS) Market Share (2019-2020)
Table 56. Japan Allergic Contact Dermatitis (ACDS) Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Allergic Contact Dermatitis (ACDS) Market Share by Type (2015-2020)
Table 58. Japan Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Allergic Contact Dermatitis (ACDS) Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Allergic Contact Dermatitis (ACDS) Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Allergic Contact Dermatitis (ACDS) Market Share (2019-2020)
Table 62. Southeast Asia Allergic Contact Dermatitis (ACDS) Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Allergic Contact Dermatitis (ACDS) Market Share by Type (2015-2020)
Table 64. Southeast Asia Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Allergic Contact Dermatitis (ACDS) Market Share by Application (2015-2020)
Table 66. India Key Players Allergic Contact Dermatitis (ACDS) Revenue (2019-2020) (Million US$)
Table 67. India Key Players Allergic Contact Dermatitis (ACDS) Market Share (2019-2020)
Table 68. India Allergic Contact Dermatitis (ACDS) Market Size by Type (2015-2020) (Million US$)
Table 69. India Allergic Contact Dermatitis (ACDS) Market Share by Type (2015-2020)
Table 70. India Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020) (Million US$)
Table 71. India Allergic Contact Dermatitis (ACDS) Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Allergic Contact Dermatitis (ACDS) Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Allergic Contact Dermatitis (ACDS) Market Share (2019-2020)
Table 74. Central & South America Allergic Contact Dermatitis (ACDS) Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Allergic Contact Dermatitis (ACDS) Market Share by Type (2015-2020)
Table 76. Central & South America Allergic Contact Dermatitis (ACDS) Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Allergic Contact Dermatitis (ACDS) Market Share by Application (2015-2020)
Table 78. Sandoz Company Details
Table 79. Sandoz Business Overview
Table 80. Sandoz Product
Table 81. Sandoz Revenue in Allergic Contact Dermatitis (ACDS) Business (2015-2020) (Million US$)
Table 82. Sandoz Recent Development
Table 83. Akorn Company Details
Table 84. Akorn Business Overview
Table 85. Akorn Product
Table 86. Akorn Revenue in Allergic Contact Dermatitis (ACDS) Business (2015-2020) (Million US$)
Table 87. Akorn Recent Development
Table 88. Perrigo Company Company Details
Table 89. Perrigo Company Business Overview
Table 90. Perrigo Company Product
Table 91. Perrigo Company Revenue in Allergic Contact Dermatitis (ACDS) Business (2015-2020) (Million US$)
Table 92. Perrigo Company Recent Development
Table 93. Taro Pharmaceuticals Company Details
Table 94. Taro Pharmaceuticals Business Overview
Table 95. Taro Pharmaceuticals Product
Table 96. Taro Pharmaceuticals Revenue in Allergic Contact Dermatitis (ACDS) Business (2015-2020) (Million US$)
Table 97. Taro Pharmaceuticals Recent Development
Table 98. Teva Pharmaceuticals Company Details
Table 99. Teva Pharmaceuticals Business Overview
Table 100. Teva Pharmaceuticals Product
Table 101. Teva Pharmaceuticals Revenue in Allergic Contact Dermatitis (ACDS) Business (2015-2020) (Million US$)
Table 102. Teva Pharmaceuticals Recent Development
Table 103. Glenmark Pharmaceuticals Company Details
Table 104. Glenmark Pharmaceuticals Business Overview
Table 105. Glenmark Pharmaceuticals Product
Table 106. Glenmark Pharmaceuticals Revenue in Allergic Contact Dermatitis (ACDS) Business (2015-2020) (Million US$)
Table 107. Glenmark Pharmaceuticals Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Allergic Contact Dermatitis (ACDS) Market Share by Type: 2020 VS 2026
Figure 2. Glucocorticoids Features
Figure 3. Topical Steroids Features
Figure 4. Miscellaneous Topical Agents Features
Figure 5. Corticosteroid Features
Figure 6. Anticholinergic Antiemetic Features
Figure 7. Miscellaneous Anxiolytics, Sedatives and Hypnotics Features
Figure 8. Global Allergic Contact Dermatitis (ACDS) Market Share by Application: 2020 VS 2026
Figure 9. Topical Administration Case Studies
Figure 10. Oral Administration Case Studies
Figure 11. Allergic Contact Dermatitis (ACDS) Report Years Considered
Figure 12. Global Allergic Contact Dermatitis (ACDS) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Allergic Contact Dermatitis (ACDS) Market Share by Regions: 2020 VS 2026
Figure 14. Global Allergic Contact Dermatitis (ACDS) Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Allergic Contact Dermatitis (ACDS) Market Share by Players in 2019
Figure 17. Global Top Allergic Contact Dermatitis (ACDS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allergic Contact Dermatitis (ACDS) as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Allergic Contact Dermatitis (ACDS) Revenue in 2019
Figure 19. North America Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Allergic Contact Dermatitis (ACDS) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed